Furthermore, SIA‐CIgG CAR‐T cells demonstrate milder tumor cell lysis and enhanced persistence compared with human epidermal growth factor receptor 2 (HER2) CAR‐T cells, which have undergone extensive clinical trials. Here, ERBB2 is linked to neoplasm.